imiquimod has been researched along with valine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Snoeck, R | 1 |
| Germain, M; Skelton, H; Smith, KJ; Yeager, J | 1 |
| Brummitt, CF | 1 |
| Bechtel, MA; Trout, W | 1 |
| Sharma, DP; Singh, J; Sinha, S; Tandon, S | 1 |
| Chen, X; Kuang, Y; Li, J; Liu, N; Liu, P; Peng, C; Yan, B; Yi, X; Zhu, W | 1 |
| Huang, C; Huang, F; Li, B; Lin, D; Wang, S; Xu, C; Zhang, T | 1 |
2 review(s) available for imiquimod and valine
| Article | Year |
|---|---|
[Perspectives for the treatment and prevention of herpes simplex infections].
Topics: 2-Aminopurine; Acyclovir; Aminoquinolines; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Simplex Virus Vaccines; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imiquimod; Interferon Inducers; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 2002 |
Sexually transmitted diseases.
Topics: Acyclovir; Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Chancre; Condylomata Acuminata; Female; Herpes Genitalis; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Penicillins; Podophyllotoxin; Sexually Transmitted Diseases; Syphilis, Cutaneous; Uterine Cervical Neoplasms; Valacyclovir; Valine | 2015 |
5 other study(ies) available for imiquimod and valine
| Article | Year |
|---|---|
Topical 5% imiquimod for the therapy of actinic cheilitis.
Topics: Acyclovir; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antiviral Agents; Cheilitis; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Stomatitis, Herpetic; Valacyclovir; Valine | 2002 |
Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
Topics: Acyclovir; Administration, Topical; Aged; Aminoquinolines; Antiviral Agents; Arthritis, Rheumatoid; Drug Resistance, Viral; Emollients; Female; Foscarnet; Herpes Genitalis; Humans; Imiquimod; Infusions, Intravenous; Treatment Outcome; Trifluridine; Valacyclovir; Valine | 2006 |
Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antiviral Agents; Drug Therapy, Combination; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Immunocompromised Host; Male; Middle Aged; Valacyclovir; Valine | 2017 |
Topical VX-509 attenuates psoriatic inflammation through the STAT3/FABP5 pathway in keratinocytes.
Topics: Animals; Disease Models, Animal; Fatty Acid-Binding Proteins; Heterocyclic Compounds, 2-Ring; Imiquimod; Inflammation; Keratinocytes; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Psoriasis; Skin; STAT3 Transcription Factor; Valine | 2022 |
NMR-based metabolomic analysis for the effects of moxibustion on imiquimod-induced psoriatic mice.
Topics: Alanine; Animals; Asparagine; Aspartic Acid; Cytokines; Disease Models, Animal; Glucose; Histidine; Imiquimod; Interleukin-17; Interleukin-23; Interleukin-8; Magnetic Resonance Spectroscopy; Mice; Moxibustion; Psoriasis; Skin; Taurine; Triglycerides; Valine | 2023 |